Drug Type AAV based gene therapy |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization DiNAQOR AGStartup |
Active Organization DiNAQOR AGStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiomyopathy, Dilated | Preclinical | CH | DiNAQOR AGStartup | - |
Cardiomyopathy, Hypertrophic | Preclinical | CH | DiNAQOR AGStartup | - |